Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
Step by step instructions to Explore the Close to home Consequence of Cellular breakdown in the lungs- The Way to Recuperation: Defeating Dependence
- Man who grabbed Ariana Grande at 'Wicked: For Good' premiere also rushed Katy Perry onstage this year. Who is he and why is he doing this?
- Tech for Learning: Online Courses and Instructive Apparatuses
- The most effective method to Settle on Informed Conclusions about Senior Insuranc.
- Banks for High Fixed Store Rates: Augment Your Investment funds
- Vote in favor of Your #1 4\u00d74 SUVs
- UN torture cm'tee report flags Israel for allegedly mistreating journalists, detainees, ex-MAG
- Blue Origin's next space tourism flight will break new ground for people with disabilities
